Companies /Healthcare

Senseonics Holdings Inc

NYSE MKT: SENS Medical Devices
$9.40
â–² $0.06 (+0.64%) today
Markets closed · 5:23pm ET
Today · % change

Fundamentals

Market Cap
$503.4M
Profit Margin
-225.3%
Revenue (TTM)
$48.5M
EPS (TTM)
$-2.24
52-Week Range
$5 – $12
Street Target
$13.40

About Senseonics

Senseonics Holdings Inc is a pioneering medical technology firm based in Germantown, Maryland, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for diabetes management. Its innovative products, including Eversense, Eversense XL, and Eversense E3, offer a unique approach to diabetes care with implantable sensors, rechargeable transmitters, and a user-friendly app. These systems provide real-time glucose level monitoring for up to six months, catering to the needs of patients and healthcare providers in the United States, Europe, the Middle East, and Africa.

SENS Coverage

8:05am ET
Investing

Meme Stocks Make a Comeback

The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.

Chris Lange